Current Pain and Headache Reports

, Volume 12, Issue 4, pp 270–276 | Cite as

Cancer pain: Perspectives of a medical oncologist

Article

Abstract

Pain is highly prevalent in cancer patients and primarily managed by medical oncologists. This article reviews cancer pain syndromes related to cancer and sequelae of treatment. We discuss the assessment and treatment of cancer pain with pharmacotherapy and chemotherapy, and the role of pain specialists. There are numerous barriers to care, which arise from both the physician and patient. We review approaches that diminish these barriers to improve treatment of cancer pain.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Henry DH, Viswanathan HN, Elkin EP, et al.: Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 2008, 16:791–801.PubMedCrossRefGoogle Scholar
  2. 2.
    van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al.: Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18:1437–1449.PubMedCrossRefGoogle Scholar
  3. 3.
    Reid CM, Forbes K: Pain in patients with cancer: still a long way to go. Pain 2007, 132:229–230.PubMedCrossRefGoogle Scholar
  4. 4.
    Caraceni A, Portenoy RK: An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer. Pain International Association for the Study of Pain. Pain 1999, 82:263–274.PubMedCrossRefGoogle Scholar
  5. 5.
    Grossman SA, Nesbit S: Cancer pain. In Clinical Oncology. Edited by Abeloff MD, Armitage JO, Niederhuber JE, et al. Philadelphia: Elsevier; 2004:715–730.Google Scholar
  6. 6.
    Bruera E, Kim HN: Cancer pain. JAMA 2003, 290:2476–2479.PubMedCrossRefGoogle Scholar
  7. 7.
    Chang VT, Janjan N, Jain S, et al.: Regional cancer pain syndromes. J Palliat Med 2006, 9:1435–1453.PubMedCrossRefGoogle Scholar
  8. 8.
    Polomano RC, Farrar JT: Pain and neuropathy in cancer survivors. Surgery, radiation, and chemotherapy can cause pain; research could improve its detection and treatment. Am J Nurs 2006, 106(Suppl 3):39–47.PubMedGoogle Scholar
  9. 9.
    Macrae WA: Chronic pain after surgery. Br J Anaesth 2001, 87:88–98.PubMedCrossRefGoogle Scholar
  10. 10.
    Rizzoli R, Burlet N, Cahall D, et al.: Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008, 42:841–847.PubMedCrossRefGoogle Scholar
  11. 11.
    Coleman RE, Bolten WW, Lansdown M, et al.: Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations. Cancer Treat Rev 2008, 34:275–282.PubMedCrossRefGoogle Scholar
  12. 12.
    Loprinzi CL, Maddocks-Christianson K, Wolf SL, et al.: The paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J 2007, 13:399–403.PubMedCrossRefGoogle Scholar
  13. 13.
    Kannarkat G, Lasher EE, Schiff D: Neurologic complications of chemotherapy agents. Curr Opin Neurol 2007, 20:719–725.PubMedGoogle Scholar
  14. 14.
    Verstappen CC, Heimans JJ, Hoekman K, et al.: Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 2003, 63:1549–1563.PubMedCrossRefGoogle Scholar
  15. 15.
    Nagore E, Insa A, Sanmartín O: Antineoplastic therapyinduced palmar plantar erythrodysesthesia (’hand-foot’) syndrome. Incidence, recognition and management. Am J Clin Dermatol 2000, 1:225–234.PubMedCrossRefGoogle Scholar
  16. 16.
    Angst MS, Clark JD: Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104:570–587.PubMedCrossRefGoogle Scholar
  17. 17.
    Bitros BS: Advocating for management of cancer pain. J Am Osteopath Assoc 2007, 107(Suppl 7):ES4–ES8.PubMedGoogle Scholar
  18. 18.
    Delgado-Guay MO, Bruera E: Management of pain in the older person with cancer. Oncology (Williston Park) 2008, 22:56–61.Google Scholar
  19. 19.
    Burton AW, Fanciullo GJ, Beasley RD, et al.: Chronic pain in the cancer survivor: a new frontier. Pain Med 2007, 8:189–198.PubMedCrossRefGoogle Scholar
  20. 20.
    Levy MH: Pharmacologic treatment of cancer pain. N Engl J Med 1996, 335:1124–1132.PubMedCrossRefGoogle Scholar
  21. 21.
    Cherny NI, Portenoy RK: Cancer pain management. Current strategy. Cancer 1993, 72:3393–3415.PubMedCrossRefGoogle Scholar
  22. 22.
    Burton AW, Rajagopal A, Cleeland CS, et al.: Management of cancer pain. JAMA 2004, 291:1067–1068; author reply 1068–1069.PubMedCrossRefGoogle Scholar
  23. 23.
    Qaseem A, Snow V, Shekelle P: Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008, 148:141–146.PubMedGoogle Scholar
  24. 24.
    Burris HA 3rd, Moore MJ, Andersen J, et al.: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997, 15:2403–2413.PubMedGoogle Scholar
  25. 25.
    The Elderly Lung Cancer Vinorelbine Italian Study Group: Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999, 91:66–72.CrossRefGoogle Scholar
  26. 26.
    Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al.: Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005, 353:123–132.PubMedCrossRefGoogle Scholar
  27. 27.
    Dancey J, Shepherd FA, Gralla RJ, et al.: Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 2004, 43:183–194.PubMedCrossRefGoogle Scholar
  28. 28.
    Tannock IF, Osoba D, Stockler MR, et al.: Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996, 14:1756–1764.PubMedGoogle Scholar
  29. 29.
    Yuen KK, Shelley M, Sze WM, et al.: Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev 2006, 4:CD006250.Google Scholar
  30. 30.
    Manfredi PL, Chandler S, Pigazzi A, et al.: Outcome of cancer pain consultations. Cancer 2000, 89:920–924.PubMedCrossRefGoogle Scholar
  31. 31.
    Kay S, Husbands E, Antrobus JH, et al.: Provision for advanced pain management techniques in adult palliative care: a national survey of anaesthetic pain specialists. Palliat Med 2007, 21:279–284.PubMedCrossRefGoogle Scholar
  32. 32.
    Von Roenn JH, Cleeland CS, Gonin R, et al.: Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993, 119:121–126.Google Scholar
  33. 33.
    Cherny NI, Catane R, Kosmidis P; ESMO Taskforce on Supportive and Palliative Care: ESMO takes a stand on supportive and palliative care. Ann Oncol 2003, 14:1335–1337.PubMedCrossRefGoogle Scholar
  34. 34.
    Detmar SB, Muller MJ, Wever LD, et al.: The patientphysician relationship. Patient-physician communication during outpatient palliative treatment visits: an observational study. JAMA 2001, 285:1351–1357.PubMedCrossRefGoogle Scholar
  35. 35.
    Potter VT, Wiseman CE, Dunn SM, et al.: Patient barriers to optimal cancer pain control. Psychooncology 2003, 12:153–160.PubMedCrossRefGoogle Scholar
  36. 36.
    Carr D, Goudas L, Lawrence D, et al.: Management of Cancer Symptoms: Pain, Depression, and Fatigue. Evidence Report/Technology Assessment No. 61. Prepared by the New England Medical Center Evidence-Based Practice Center Under Contract No 290-97-0019. AHRQ Publication; 2002: 02-E032.Google Scholar
  37. 37.
    Swarm R, Anghelescu DL, Benedetti C, et al.: Adult cancer pain. J Natl Compr Canc Netw 2007, 5:726–751.PubMedGoogle Scholar
  38. 38.
    Cancer Pain Assessment and Treatment Curriculum Guidelines. The Ad Hoc Committee on Cancer Pain of the American Society of Clinical Oncology. J Clin Oncol 1992, 10: 1976–1982.Google Scholar
  39. 39.
    Münger-Beyeler C, Bernhard J, Rufibach K, et al.: Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience. Support Care Cancer 2008, 16:461–467.PubMedCrossRefGoogle Scholar
  40. 40.
    Du Pen SL, Du Pen AR, Polissar N, et al.: Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. J Clin Oncol 1999, 17:361–370.PubMedGoogle Scholar
  41. 41.
    Cohen MZ, Easley MK, Ellis C, et al.: Cancer pain management and the JCAHO’s pain standards: an institutional challenge. J Pain Symptom Manage 2003, 25:519–527.PubMedCrossRefGoogle Scholar
  42. 42.
    Miaskowski C, Dodd M, West C, et al.: Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. J Clin Oncol 2004, 22:1713–1720.PubMedCrossRefGoogle Scholar
  43. 43.
    Syrjala KL, Abrams JR, Polissar NL, et al.: Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain 2008, 135:175–186.PubMedCrossRefGoogle Scholar
  44. 44.
    Anderson KO, Mendoza TR, Payne R, et al.: Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol 2004, 22:4918–4925.PubMedCrossRefGoogle Scholar
  45. 45.
    Goldberg GR, Morrison RS: Pain management in hospitalized cancer patients: a systematic review. J Clin Oncol 2007, 25:1792–1801.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  1. 1.Seattle Cancer Care AllianceUniversity of WashingtonSeattleUSA

Personalised recommendations